000			01712 a2200469 4500
005			20250515204336.0
264		0	_c20100903
008			201009s 0 0 fre d
022			_a0151-9638
024	7		_a10.1016/S0151-9638(09)73385-X _2doi
040			_aNLM _beng _cNLM
100	1		_aBagot, M
245	0	0	_a[What's new in oncodermatology?]. _h[electronic resource]
260			_bAnnales de dermatologie et de venereologie _cDec 2009
300			_aS436-44 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aCarcinoma, Basal Cell
650	0	4	_aCarcinoma, Merkel Cell
650	0	4	_aDermatology _xtrends
650	0	4	_aEvidence-Based Medicine
650	0	4	_aFrance _xepidemiology
650	0	4	_aGlucocorticoids _xadverse effects
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aIncidence
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aLymphoma _xdrug therapy
650	0	4	_aLymphoma, B-Cell
650	0	4	_aLymphoma, T-Cell, Cutaneous
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aPesticides _xadverse effects
650	0	4	_aPrognosis
650	0	4	_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors
650	0	4	_aRisk Factors
650	0	4	_aSEER Program
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aUnited States _xepidemiology
773	0		_tAnnales de dermatologie et de venereologie _gvol. 136 Suppl 7 _gp. S436-44
856	4	0	_uhttps://doi.org/10.1016/S0151-9638(09)73385-X _zAvailable from publisher's website
999			_c19484864 _d19484864